Moleculin Biotech Inc

General ticker "MBRX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $8.9M

Moleculin Biotech Inc does not follow the US Stock Market performance with the rate: -41.9%.

Estimated limits based on current volatility of 8.7%: low 1.56$, high 1.86$

Factors to consider:

  • Current price 73.5% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [6.53$, 17.20$]
  • 2024-12-30 to 2025-12-30 estimated range: [4.99$, 13.12$]

Financial Metrics affecting the MBRX estimates:

  • Negative: Non-GAAP EPS, $ of -15.07 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -57.79 <= 2.35
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Inventory ratio change, % of -100 <= -1.03

Similar symbols

Short-term MBRX quotes

Long-term MBRX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $22.97MM $30.64MM $29.63MM
Operating Income $-22.97MM $-30.64MM $-29.63MM
Non-Operating Income $7.07MM $1.61MM $-0.14MM
R&D Expense $14.42MM $18.97MM $19.49MM
Income(Loss) $-15.89MM $-29.02MM $-29.77MM
Profit(Loss) $-15.89MM $-29.02MM $-29.77MM
Stockholders Equity $78.99MM $52.19MM $26.07MM
Inventory $0.04MM $0.02MM $0.00MM
Assets $84.09MM $57.42MM $38.22MM
Operating Cash Flow $-18.95MM $-27.64MM $-24.10MM
Capital expenditure $0.02MM $0.07MM $0.12MM
Investing Cash Flow $-0.02MM $-0.07MM $-0.12MM
Financing Cash Flow $74.72MM $-0.02MM $4.65MM
Earnings Per Share* $-4.94 $-14.37 $-15.07

* EPS are Split Adjusted, recent splits may be reflected with a delay.